L&C BIO Co., Ltd Logo

L&C BIO Co., Ltd

Develops and manufactures human tissue-based medical devices for regenerative medicine.

290650 | KO

Overview

Corporate Details

ISIN(s):
KR7290650001
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 둔촌대로 474, 605호, 606호, 607호 (선텍시티), 성남시

Description

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-12-16 00:00
현금ㆍ현물배당결정
Korean 8.9 KB
2025-09-19 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-26 00:00
자기주식취득결과보고서
Korean 35.7 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-10 00:00
주식등의대량보유상황보고서(약식)
Korean 73.0 KB
2025-07-10 00:00
주식등의대량보유상황보고서(약식)
Korean 79.5 KB
2025-06-30 00:00
주식등의대량보유상황보고서(일반)
Korean 143.2 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-06-23 00:00
주요사항보고서(자기주식취득결정)
Korean 32.8 KB
2025-06-16 00:00
[기재정정]교환사채권발행결정(종속회사의주요경영사항)
Korean 36.9 KB
2025-06-12 00:00
교환사채권발행결정(종속회사의주요경영사항)
Korean 32.6 KB
2025-06-12 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 79.9 KB
2025-06-10 00:00
주식등의대량보유상황보고서(약식)
Korean 75.3 KB
2025-05-27 00:00
[기재정정]전환청구권행사
Korean 12.7 KB

Automate Your Workflow. Get a real-time feed of all L&C BIO Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for L&C BIO Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for L&C BIO Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.